A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : OHSS / ovarian hyperstimulation syndrome

[Related PubMed/MEDLINE]
Total Number of Papers: 1600
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   OHSS  (>> Co-occurring Abbreviation)
Long Form:   ovarian hyperstimulation syndrome
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A 10-year follow-up on the practice of luteal phase support using worldwide web-based surveys. ART, IVF, LPS
2021 A comprehensive evaluation of progestin-primed ovarian stimulation protocol in patients with or without PCOS undergoing in vitro fertilization. COH, PCOS, PPOS
2021 A Histopathological Evaluation of Ovarian Hyperstimulation Syndrome on Reproductive and Vital Organs and the Role of the VEGF-PKA Pathway in a Mouse Model. PKA, VEGF
2021 A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS. COS, PCOS
2021 A new instrument to personalize ovarian stimulation: results of the CERES study after using a novel gonadotropin - follitropin delta. AMH, CERES
2021 A Prospective Randomised Comparative Clinical Trial Study of Luteal PhaseLetrozole versus Ganirelix Acetate Administration to Prevent Severity of Early Onset OHSS in ARTs. ARTs, GnRH, ICSI, IVF
2021 A qualitative study on couples' attitudes and concerns regarding a freeze all strategy in ART treatment. ART, RCT
2021 A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients. AMH
2021 A rare presentation of isolated right-sided pleural effusion in the context of ovarian hyperstimulation syndrome: A case report. ---
10  2021 An unusually prolonged course of late onset severe OHSS with successful outcome - a rare but avoidable complication. COS
11  2021 Annual incidence of severe ovarian hyperstimulation syndrome. ICSI, IVF
12  2021 Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome. ART, PCOS
13  2021 Anti-Mullerian Hormone Predictive Levels to Determine The Likelihood of Ovarian Hyper-Response in Infertile Women with Polycystic Ovarian Morphology. AMH, ART, AUC, CI, PCOM, ROC
14  2021 Assessing couples' preferences for fresh or frozen embryo transfer: a discrete choice experiment. DCE
15  2021 Assisted reproductive medicine in Poland, 2013-2016: Polish Society of Reproductive Medicine and Embryology (PTMRiE) and Fertility and Sterility Special Interest Group of the Polish Society of Gynaecologists and Obstetricians (SPiN PTGiP) report. ART, EIM, ESHRE, FER, IUI, IUI-H, PTMRiE
16  2021 Association of ABO blood groups with ovarian reserve, and outcomes after assisted reproductive technology: systematic review and meta-analyses. ART, CI, CPR, CPR, DOR, LBR, MR
17  2021 Association of ovarian response with picoAMH in women undergoing controlled ovarian hyperstimulation. AFC, AUC, COH, picoAMH, ROC
18  2021 Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study. ---
19  2021 Chinese herbal medicine for subfertile women with polycystic ovarian syndrome. CHM, CI, CIs, EE/CPA, GRADE, LOD, LUFS, OR, ORs, PCOS, RCTs
20  2021 Clinical and perinatal outcomes of fresh single-blastocyst-transfer cycles under an early follicular phase prolonged protocol according to day of trigger estradiol levels. AUC, GDM, NICU, PPROM, PROM, SBT
21  2021 Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight. AMH
22  2021 Clinical Pregnancy and Incidence of Ovarian Hyperstimulation Syndrome in High Ovarian Responders Receiving Different Doses of hCG Supplementation in a GnRH-Agonist Trigger Protocol. hCG, ICSI, IVF
23  2021 Coagulation and Fibrinolysis Biomarkers as Potential Indicators for the Diagnosis and Classification of Ovarian Hyperstimulation Syndrome. AUCs, PIC, sTM, t-PAIC, TAT
24  2021 Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders. Gn, GnRH, ICSI-ET, IVF-ET
25  2021 Comparison of the Long-Acting GnRH Agonist Follicular Protocol with the GnRH Antagonist Protocol in Women Undergoing In Vitro Fertilization: A Systematic Review and Meta-analysis. CI, IVF, RR
26  2021 Correlation between anti-Mullerian hormone levels and antral follicle counts in polycystic ovary and metabolic syndromes. AFC, AMH, BMI, PCOS
27  2021 Current possibilities in the prevention and therapy of ovarian hyperstimulation syndrome. ---
28  2021 Diagnostic Complexities in a Case of Ovarian Hyperstimulation Syndrome Presented Solely as a Unilateral Massive Hydrothorax. ---
29  2021 Do we trust scientific evidence? A multicentre retrospective analysis of first IVF/ICSI cycles before and after the OPTIMIST trial. ART, HRs, ICSI, IVF, NR, POR, RCT
30  2021 Does the additional use of clomiphene citrate or letrozole for in vitro fertilization deserve more attention? CC, IVF, LE
31  2021 Does the freeze-all strategy improve the cumulative live birth rate and the time to become pregnant in IVF cycles? BELRAP, CLBR, FA, FET
32  2021 Dopamine agonists for preventing ovarian hyperstimulation syndrome. ART, CI, IVF, OR, RCTs
33  2021 Dual Trigger Compared with Human Chorionic Gonadotropin Alone and Effects on Clinical Outcome of Intracytoplasmic Sperm Injection. ART, CPR, GnRH, hCG, ICSI, OPR
34  2021 Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles. GnRHa, hCG, IVF, LH
35  2021 Dydrogesterone supplementation in addition to routine micronized progesterone administration for luteal support in cycles triggered with lone GnRH agonist results in an acceptable pregnancy rate and avoids the need to freeze embryos. FSH, GnRH, hCG, LH
36  2021 Effect and Relationship of Seasons on the High Risk of Ovarian Hyperstimulation Syndrome After Oocyte Retrieval in Patients With Polycystic Ovary Syndrome. PCOS
37  2021 Effect of kisspeptin-54 on ovarian levels of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in an experimental model of ovarian hyperstimulation syndrome (OHSS). PEDF, PKA, PKC, VEGF
38  2021 Effects of controlled ovarian stimulation on vascular barrier and endothelial glycocalyx: a pilot study. EGX
39  2021 Effects of oral contraceptive for different responder women before GnRH antagonists: a systematic review and meta-analysis. CIs, CNKI, GnRH-ant, ICSI, IVF, OCP, RRs, SMDs
40  2021 Electroacupuncture Reduces Oocyte Number and Maintains Vascular Barrier Against Ovarian Hyperstimulation Syndrome by Regulating CD200. CM, EA, hCG, HUVECs
41  2021 Embryo Morphokinetics and Blastocyst Development After GnRH Agonist versus hCG Triggering in Normo-ovulatory Women: a Secondary Analysis of a Multicenter Randomized Controlled Trial. GnRHa, hCG
42  2021 Exosomal miR-27 negatively regulates ROS production and promotes granulosa cells apoptosis by targeting SPRY2 in OHSS. COH
43  2021 Expression of tissue factor and tissue factor pathway inhibitors during ovulation in rats: a relevance to the ovarian hyperstimulation syndrome. hCG, PPARgamma, qPCR, TFPI
44  2021 Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI. AFC, AMH, ART, BMI, COH, FSH, ICSI, IVF, PCOS
45  2021 Female age is associated with the optimal number of oocytes to maximize fresh live birth rates: an analysis of 256,643 fresh ART cycles. ART, LBR
46  2021 Follitropin Delta as a State-of-the-Art Incorporated Companion for Assisted Reproductive Procedures: A Two Year Observational Study. AMH, ARTs, rhFSH
47  2021 Fresh embryo transfer versus freeze-only after in vitro maturation with a pre-maturation step in women with high antral follicle count: a randomized controlled pilot study. AFC, ET, IVF
48  2021 Fresh versus frozen embryo transfers in assisted reproduction. ICSI, MD, OR
49  2021 Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a rat model. eCG, hCG, hCG, IVF/ICSI, VEGF, VEGFR
50  2021 Growth hormone for in vitro fertilisation (IVF). CGF, CI, GH, IVF, MD, OR, RCTs
51  2021 High Dose Cabergoline in Management of Bilateral Ovarian Hyperstimulation Syndrome: A Case Report. hCG
52  2021 High ovarian GDF-8 levels contribute to elevated estradiol production in ovarian hyperstimulation syndrome by stimulating aromatase expression. GDF8, hGL, TGF-beta
53  2021 How frequent is severe ovarian hyperstimulation syndrome after GnRH agonist triggering in high-risk women? A systematic review and meta-analysis. GnRHa
54  2021 Hyponatremia: An Untimely Finding in Ovarian Hyper-Stimulation Syndrome. ICU, IVF
55  2021 In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial. CI, IVF, IVM, PCOS
56  2021 Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF/ICSI patients: a randomized controlled trial. AMH
57  2021 Investigation on the risk factors for late-onset OHSS: a retrospective case-control study. LDL-C, TC
58  2021 Ischemic Stroke Associated With Ovarian Hyperstimulation Syndrome. ED
59  2021 Live births after in vitro maturation of oocytes in women who had suffered adnexal torsion and unilateral oophorectomy following conventional ovarian stimulation. IVM
60  2021 Low dose hCG supplementation in a Gn-RH-agonist trigger protocol is associated with worse pregnancy outcomes: a retrospective cohort study. GnRHa, IVF
61  2021 Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF. COS, CS, ET, hCG, IR, IVF, LBR, PCO
62  2021 Mechanical thrombectomy for middle cerebral artery occlusion associated with ovarian hyperstimulation syndrome: case report and review of the literature. CTA, LMCA, MT, tPA
63  2021 Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). CI, COH, ICSI, IVF, MD, OR, TVUS
64  2021 Myxedema crisis and ovarian hyperstimulation in a child with Down syndrome. ---
65  2021 Neutrophil:lymphocyte and estradiol:progesterone ratios as predictive markers for ovarian hyperstimulation syndrome (OHSS). HR, NLR, NR
66  2021 Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome. AUC, IVF/ICSI, PCOS
67  2021 Nomograms for predicting adverse obstetric outcome in IVF pregnancy: A preliminary study. GW, IVF
68  2021 Oocyte or embryo number needed to optimize live birth and cumulative live birth rates in mild stimulation IVF cycles. CLBR, FET, LBR, MS-IVF
69  2021 Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus. ART, GnRH, hCG, hMG, rhFSH
70  2021 Ovarian hyperstimulation syndrome and adverse pregnancy outcome: a systematic review and meta-analysis. CS, GDM, IUD, PE, PTB
71  2021 Ovarian Hyperstimulation Syndrome Complicating Spontaneous Molar Pregnancy: A Case Report and Review of the Literature. ---
72  2021 Ovarian Hyperstimulation Syndrome Is Associated with a High Secondary Sex Ratio in Fresh IVF Cycles with Cleavage-Stage Embryo Transfer: Results for a Cohort Study. ART, COS, SSR
73  2021 Ovarian Hyperstimulation: Diagnosis, Prevention, and Management. COS, GnRH, LDA, VTE
74  2021 Ovarian stimulation for oocyte donation: a systematic review and meta-analysis. MD, OD, OR, OS, SR
75  2021 Overview of hospitalizations in women undergoing oocyte retrieval for ART in the French national health data system. FP, IF, OD, PM
76  2021 Patients with IVF complicated by moderate-to-critical OHSS experience increased thrombosis, GDM and neonatal NICU admission but slightly shorter gestation compared with matched IVF counterparts: A retrospective Chinese cohort study. ET, GDM, HDP, ICP, LBW, PP, VT
77  2021 Plasma and follicular fluid osteopontin levels during ovarian cycle and their correlation with follicular fluid vascular endothelial growth factor levels. FF, OPN, VEGF
78  2021 Prednisone combined with letrozole reduced risk of ovarian hyperstimulation syndrome (OHSS) in women undergoing long-term gonadotropin-releasing hormone analog treatment. COH, GnRHa, ICSI, IVF
79  2021 Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing in vitro fertilization treatments with frozen-thawed embryo transfer: a prospective randomized controlled trial. FET, GnRH-ant, ICSI, IVF, LH, PCOS
80  2021 Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol. FET, GnRHant, PCOS, PPOS
81  2021 Progestin-Primed Ovarian Stimulation Protocol for Patients in Assisted Reproductive Technology: A Meta-Analysis of Randomized Controlled Trials. DOR, GnRH, LH, NOR, PPOS, RCTs
82  2021 Right neck venous thrombosis following ovarian hyperstimulation syndrome in a patient with protein S deficiency: A case report and review of literature. ART, LMWH
83  2021 Risk factors for the development of endometrial fluid in women undergoing IVF: A retrospective cohort study✰. aOR, EF, FAE, PCOS
84  2021 Safety and efficacy of invitro fertilisation in patients with chronic liver disease and liver transplantation recipients. AIH, IVF, LBR, LRSF, LT, OC
85  2021 Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study. SOFIA
86  2021 Self-Monitoring of Urinary Hormones in Combination with Telemedicine - a Timely Review and Opinion Piece in Medically Assisted Reproduction. MAR
87  2021 Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report. AMH, BMI, COS
88  2021 Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients. COH
89  2021 Severe Ovarian Hyperstimulation Syndrome in a Case of Nonmutated Recurrent Genuine Empty Follicle Syndrome. ART, EFS, hCG
90  2021 sRAGE downregulates the VEGF expression in OHSS ovarian granulosa cells. AREG, BTC, EREG, FF, hCG, sRAGE, VEGF
91  2021 Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels. AMH, rFSH
92  2021 The Association between Ovarian Hyperstimulation Syndrome and Pregnancy Complications following Fertility Treatments. aOR, CI, GDM, IUGR, IVF, LBW, OI, SGA, VLBW
93  2021 The Effect of Luteinising Hormone Suppression in In Vitro Fertilisation Antagonist Cycles. COH
94  2021 The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patients. GnRHa, hCG, LPS, ORD, RCT
95  2021 The Improvement and Clinical Application of Human Oocyte In Vitro Maturation (IVM). IVM
96  2021 The influence of obesity on incidence of complications in patients hospitalized with ovarian hyperstimulation syndrome. ---
97  2021 The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART. KPIs, LBR, OPU, PIs
98  2021 Two cases of polycystic ovary syndrome with onset of severe ovarian hyperstimulation syndrome following controlled ovarian stimulation with aromatase inhibitors for fertility preservation before breast cancer treatment. AI, COS, VEGF
99  2021 When Should We Freeze Embryos? Current Data for Fresh and Frozen Embryo Replacement IVF Cycles. FER, PGT-A
100  2020 A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with hCG. Ht, MOD, WBC